Search results
Inhibrx Biosciences Inc. (INBX) - News - Insider Monkey
Insider Monkey· 4 days agoInhibrx Biosciences Inc. (INBX) latest news, insider trading and hedge fund ownership data provided by Insider Monkey.
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?
Zacks· 2 days agoFree Report) need to pay close attention to the stock based on moves in the options market lately. What is Implied Volatility? Implied volatility shows how much movement the market is expecting ...
What's Driving Twist Bioscience Corp's Surprising 15% Stock Rall
Guru Focus· 6 days agoTwist Bioscience Corp (TWST, Financial), a prominent player in the Medical Diagnostics & Research industry, has demonstrated a notable performance in the stock market recently ...
Nu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC...
Benzinga· 5 days agoNu-Tek BioSciences is an innovative manufacturer of critical raw materials used in cell culture media for the development and manufacturing of pharmaceuticals. Nu-Tek has ...
Genflow Biosciences PLC Announces Notice of AGM
Morningstar· 6 days agoGenflow Biosciences PlcNotice of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF ...
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Morningstar· 3 days agoSAN DIEGO, CA / ACCESSWIRE / June 6, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative ...
Coherus Biosciences Inc [CHRS] Records 50-Day SMA of $2.1258 – Knox Daily
Knox Daily· 2 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Coherus Biosciences Inc shares valued at $449,770 ...
Citi maintains buy on Arcus Biosciences stock By Investing.com
Investing.com· 6 days agoOn Monday, Citi reaffirmed its Buy rating and $38.00 price target for Arcus Biosciences (NYSE:RCUS),...
Morgan Stanley cuts Akoya Biosciences stock target, keeps overweight By Investing.com
Investing.com· 6 days agoOn Monday, Morgan Stanley (NYSE:MS) adjusted its outlook on Akoya Biosciences Inc (NASDAQ:AKYA),...
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major...
Benzinga· 5 days agoSpruce Biosciences Inc. SPRB and HMNC Brain Health GmbH have collaborated to develop Spruce’s investigational product candidate, tildacerfont, and HMNC’s companion diagnostic ...